This topic contains a solution. Click here to go to the answer

Author Question: While counseling a patient with cystic fibrosis who is beginning to use inhaled tobramycin, it is ... (Read 105 times)

dbose

  • Hero Member
  • *****
  • Posts: 597
While counseling a patient with cystic fibrosis who is beginning to use inhaled tobramycin, it is important to discuss the potential development of:
 
  1. hearing loss.
  2. reduced pulmonary function.
  3. tinnitus.
  4. bleeding.

Question 2

A patient is diagnosed with pulmonary arterial hypertension. Which nursing diagnosis would have the highest priority to add to the plan of care?
 
  1. Risk for decreased cardiac output
  2. Risk for impaired role performance
  3. Risk for a disturbed sleep pattern
  4. Risk for disturbed sensory perception



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bpool94

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

Correct Answer: 3

Answer to Question 2

Correct Answer: 1





 

Did you know?

The oldest recorded age was 122. Madame Jeanne Calment was born in France in 1875 and died in 1997. She was a vegetarian and loved olive oil, port wine, and chocolate.

Did you know?

The top 10 most important tips that will help you grow old gracefully include (1) quit smoking, (2) keep your weight down, (3) take supplements, (4) skip a meal each day or fast 1 day per week, (5) get a pet, (6) get medical help for chronic pain, (7) walk regularly, (8) reduce arguments, (9) put live plants in your living space, and (10) do some weight training.

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library